10x Genomics Inc Ordinary Shares - Class A (TXG)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$15.85
Buy
$15.88
$-0.135 (-0.84%)
Prices updated at 19 Dec 2025, 15:10 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 619m | 611m | |
| 409m | 414m | |
| -204m | -195m | |
| -33.03 | -31.85 | |
| -255m | -183m | |
| -205m | -134m | |
| Sales, General and administrative | 343m | 344m |
| Interest expenses | 33,000 | 4,000 |
| Provision for income taxes | 6m | 5m |
| Operating expenses | 614m | 609m |
| Income before taxes | -249m | -178m |
| Net income available to common shareholders | -255m | -183m |
| -2.18 | -1.52 | |
| Net interest income | 17m | 18m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -2.18 | -1.52 |
| Free cash flow per share | -0.9727 | 0.2092 |
| Book value/share | 6.2573 | 5.9105 |
| Debt equity ratio | 0.11315 | 0.103258 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 596m | 584m |
| Current liabilities | 127m | 118m |
| Total capital | 741m | 710m |
| Total debt | 95m | 83m |
| Total equity | 741m | 710m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 965m | 919m |
| Total liabilities | - | - |
| Cash and cash equivalents | 359m | 344m |
| Common stock | 119m | 122m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 227m | 359m |
| Cash dividends paid | - | - |
| -65m | -7m | |
| Investments (gains) losses | 133m | -33m |
| 359m | 344m | |
| Net income | - | - |
| -15m | 7m | |
| -50m | -13m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
